New analysis backs use of Takeda’s Entyvio
admin 18th October 2017 Uncategorised 0Takeda has presented data from a post-hoc analysis showing signs of early symptomatic improvement in patients with ulcerative colitis or Crohn’s disease taking Entyvio.
More: New analysis backs use of Takeda’s Entyvio
Source: News